Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Treasury Shares (2020 - 2025)

Mereo BioPharma (MREO) has disclosed Treasury Shares for 4 consecutive years, with $1.2 million as the latest value for Q4 2023.

  • Quarterly Treasury Shares fell 7.87% to $1.2 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2023, down 7.87% year-over-year, with the annual reading at $1.2 million for FY2023, 7.87% down from the prior year.
  • Treasury Shares for Q4 2025 was $458375.0 at Mereo BioPharma, down from $979608.0 in the prior quarter.
  • The five-year high for Treasury Shares was $1.3 million in Q1 2024, with the low at $458375.0 in Q4 2025.
  • Average Treasury Shares over 3 years is $913874.9, with a median of $923400.0 recorded in 2023.
  • The sharpest move saw Treasury Shares decreased 13.13% in 2022, then decreased 7.87% in 2023.
  • Over 4 years, Treasury Shares stood at $1.7 million in 2020, then dropped by 10.82% to $1.5 million in 2021, then fell by 13.13% to $1.3 million in 2022, then dropped by 7.87% to $1.2 million in 2023.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.2 million, $1.3 million, and $1.5 million for Q4 2023, Q4 2022, and Q4 2021 respectively.